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Loss-of-function mutations in Kv7.1 often lead to long QT syndrome (LQTS), a cardiac
repolarization disorder associated with arrhythmia and subsequent sudden cardiac death. The
discovery of agonistic IKs modulators may offer a new potential strategy in pharmacological
treatment of this disorder. The benzodiazepine derivative (R)-L3 potently activates Kv7.1
channels and shortens action potential duration, thus may represent a starting point for drug
development. However, the molecular mechanisms underlying modulation by (R)-L3 are still
unknown. By combining alanine scanning mutagenesis, non-canonical amino acid incorporation, voltage-clamp electrophysiology and ﬂuorometry, and in silico protein modelling, we
show that (R)-L3 not only stimulates currents by allosteric modulation of the pore domain but
also alters the kinetics independently from the pore domain effects. We identify novel (R)-L3interacting key residues in the lower S4-segment of Kv7.1 and observed an uncoupling of the
outer S4 segment with the inner S5, S6 and selectivity ﬁlter segments.
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channels are the founding members of voltage-gated
Kv7 delayed rectiﬁer potassium channels (Kv), that play
important roles in various tissues including epithelia,
brain, heart, and inner ear organs1,2. In native tissues, Kv7.1 αsubunits (encoded by KCNQ1) can interact with various ancillary
subunits or modulatory proteins, which constitute the biophysical
properties of the channel producing functionally distinct K
+-currents3–7. In cardiac myocytes, co-assembling of the poreforming α-subunit and its regulatory β-subunit KCNE1 (mink,
IsK) generates the slow component of the cardiac delayed rectiﬁer
potassium current IKs that is critical for the repolarization of the
cardiac action potential8,9. Loss-of-function mutations in Kv7.1
can lead to prolonged cardiac repolarization and cause long QT
syndrome (LQTS), a genetically heterogeneous cardiac arrhythmia that is characterized by a prolonged ventricular repolarization phase10–12. Recently, diabetes was linked to KCNQ1 as
well13–17. Furthermore, Kv7.1 channels are important in many
other organs and contribute to different physiological
functions1,2,4. Thus, Kv7.1 channel modulators hold the potential
for the development of new pharmacological strategies in the
treatment of many diseases like cardiac arrhythmias, diabetes,
diarrhea, impaired function of the thyroid gland and others.
Homomeric Kv7.1 channels exhibit activation upon membrane
depolarization and undergo delayed partial inactivation. This
delayed slow inactivation cannot be observed directly upon
channel activation but becomes observable when the membrane is
stepped to hyperpolarized potentials after extended channel (in)
activation and channels switch from inactivated to activated states
before closing. A characteristic hook in the tail can thus be seen in
the current traces. These characteristics of Kv7.1 gating have been
proposed to be the result of at least two open states that need to
be occupied during the gating process, from which the channel
can enter ﬂicker states with several sub-conductive states18–20.
The prototypic high potency activator of Kv7.1 is the benzodiazepine derivative (R)-L3 (L-364,373), which leads to increased
IKs current amplitude, shortens action potential duration in guinea pig cardiac myocytes and suppresses early afterdepolarizations in rabbit ventricular myocytes21,22. The Kv7.1
channel modulation by (R)-L3 is associated with pronounced
alterations of gating parameters21,23. (R)-L3 appears to arrest the
channel in closed and open states and therefore prevent the
channel from entering the inactivated state, which is appreciable
as an absent hook in the tail currents23. Thus, the presence of (R)L3 seems to reduce or eliminate a particular gating transition
towards sub-conductive states. The β-subunit KCNE1 increases
channel conductance, slows channel activation and deactivation
and markedly reduces macroscopic inactivation as well8,9,19,24–27.
Thus, (R)-L3 and KCNE1 cause somewhat similar effects on
Kv7.1 channel.
Given the therapeutic potential of (R)-L3-like compounds, a
strong interest in deﬁning the compound binding site and
understanding its molecular mechanism of action exists. Previous
data revealed that speciﬁc residues in the Kv7.1 pore domain
interact with (R)-L3 allowing the compound to slow Kv7.1 channel
kinetics and increase the ion channel current23. However, the
precise molecular mechanism of channel modulation remained
elusive. Some of the previously identiﬁed amino acids, that have a
high impact on (R)-L3 activity, are located at the interface between
voltage-sensor and pore domain. Thus, this study suggests that the
voltage-sensor domain (VSD) might be an important structural
target to develop speciﬁc Kv7 channel agonists28.
We hypothesized that since (R)-L3 changes the activation and
deactivation kinetics and the voltage-dependency of Kv7.1 activation, (R)-L3 may also physically interact with the VSD. To
address this question, we systematically probed the lower
S4 segment of Kv7.1 via site-directed mutagenesis and
2

v7.1

COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-022-03229-8

subsequently analyzed mutated channel parameters in the
absence and presence of (R)-L3. To gain insights into the molecular mechanism of action, we performed experimental data
guided 3D-modeling of Kv7.1 and (R)-L3 to identify the complete
binding site. Subsequent molecular dynamics simulations were
utilized to assess the stability of drug binding and to explore the
binding mode of the drug.
Results
(R)-L3 activates hKv7.1 channels expressed in Xenopus oocytes.
In this study, we extend our analysis of the putative (R)-L3
(Fig. 1a) binding site towards the VSD by two-electrode voltageclamp experiments using hKv7.1 expressing Xenopus laevis
oocytes (Fig. 1b, c). In agreement with our previous electrophysiological studies, we ﬁnd a robust Kv7.1 agonism by (R)-L323,
which is characterized by an EC50 value of 4.2 ± 3.5 µM (n = 20;
SE) and a maximum activation by 212 ± 55% (SE, Fig. 1d). In
accordance with our previous data, (R)-L3 shifts the voltagedependent activation from −20 ± 1 mV (SE) to −28 ± 1 mV for
V1/2 (SE, Fig. 1e). More pronounced alterations can be observed
for the activation and deactivation kinetics (Fig. 1f–i). 1 µM (R)L3 increases the time constants for fast activation (τfast act.) as well
as for the slow deactivation (τslow deact.) components leading to
slowed activation and deactivation of the channel.
(R)-L3 activation properties depend on ion composition. The
observed effects of (R)-L3 result from direct interactions with the
Kv7.1 channel. To specify if the observed effects are a result from
direct interactions with the pore domain (PD), we tested whether
changing the permeating ion can inﬂuence the modulating
properties of (R)-L3. Therefore, we conducted recordings using
1 µM (R)-L3 with 100 mM K+ and 100 mM Rb+ containing
buffers (Fig. 2a, b). Interestingly, the activation of corrected
(inward) tail current amplitude was slightly but not signiﬁcantly
reduced in high Rb+ (42 ± 5%, SEM, n = 18) compared to K+
(54 ± 8%, SEM, n = 17, Fig. 2c). Although direct comparison of
effects is difﬁcult since external K+ has effects on the onset of
channel inactivation29, activation of corrected tail current
amplitude in ND96 (96 Na+/4 mM K+) is signiﬁcantly larger
(84 ± 7%, SEM, n = 30). The previous observed shift of V1/2 in the
presence of (R)-L3 in ND96 is weakened in high K+/Rb+ (Fig. 2d,
e). In 100 mM K+ buffer V1/2 shifts from −30 ± 1 mV (SE) to
−31 ± 1 mV (SE) in the presence of (R)-L3, while V1/2 in 100 mM
Rb+ is reduced from −42 ± 1 mV (SE) to −47 ± 2 mV (SE). On
the other hand, the modulation of fast and slow deactivation
kinetics in the presence of (R)-L3 in high K+/Rb+ buffers are
similar to the observed modulation in ND96 leading to unaffected
fast and increased slow deactivation time constants (Fig. 2f, g, SI
Fig. 1). Summarizing these results, the effects of (R)-L3 are
modulated by different external ion species implicating a direct
effect on the pore domain. Moreover, the results are in accordance with our previous study identiﬁed several residues from the
pore-forming S5 and S6 helix, that signiﬁcantly decrease the
efﬁciency of (R)-L3 (Fig. 2h)23. Taken together, the (R)-L3 effects
partially depend on a direct inﬂuence on the pore domain.
VSD movement is altered in the presence of (R)-L3. Several
previous identiﬁed amino acids crucial for compound activity are
located at the interface between VSD and PD. Especially residues
from the outer S5 helix orientated to VSD like Y267, L271 and
G272 have a high impact on compound activity implicating
possible interactions of (R)-L3 with the VSD as well (Fig. 2h). To
analyze if the (R)-L3 interaction affects voltage-dependent
movements of the VSD, we performed voltage-clamp ﬂuorometry (VCF) experiments, that connect VSD movement to the

COMMUNICATIONS BIOLOGY | (2022)5:301 | https://doi.org/10.1038/s42003-022-03229-8 | www.nature.com/commsbio

COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-022-03229-8

ARTICLE

Fig. 1 (R)-L3 activates and slows the rates of activation and deactivation of hKv7.1 channels expressed in Xenopus oocytes. a Chemical structure of (R)L3. b Pulse sequences for voltage-clamp experiments. c Effect of 1 µM (R)-L3 on hKv7.1 currents, recorded in an oocyte by a 7-s pulse to potentials of
−100 mV to +60 mV from a holding potential of −80 mV. Currents were recorded in control solution containing 0.1% DMSO followed by perfusion with
1 μM (R)-L3 containing solution. d Dose–response curve for (R)-L3 from hKv7.1 expressing oocytes at +40 mV test voltage. Each concentration was applied
to four independent oocytes (n = 20) e Voltage dependence of current activation in the absence (black; n = 13) and presence of (R)-L3 (gray; n = 15)
determined from peak tail currents measured at −120 mV. Currents were normalized to the peak tail currents elicited after a pulse to +40 mV. f–i Kinetics
were evaluated in both absence (black; ctrl) and presence (gray; +(R)-L3) of 1 µM (R)-L3 and ﬁtted by a two-component exponential function. Time
constants are calculated for individual oocytes and given for fast (f; n = 9 for both conditions) and for slow (g; n = 9 for ctrl, n = 8 for + (R)-L3) component
of Kv7.1 activation as well as for fast (h; n = 8 for ctrl, n = 6 for + (R)-L3) and for slow (i; n = 7 for ctrl, n = 8 for + (R)-L3)) component of Kv7.1
deactivation. Signiﬁcance of mean differences was analyzed by one-way ANOVA and posthoc mean comparison Tukey test (*p < 0.05, ***p < 0.001).

Fig. 2 Effect of (R)-L3 on hKv7.1 in high K+ and Rb+ buffer. a, b Representative current traces in 100 mM K+ (a) and 100 mM Rb+ (b) before (black; ctrl)
and after (gray; +(R)-L3) addition of 1 µM (R)-L3. c Activation of hKv7.1 channel currents by 1 µM (R)-L3 expressed as percent change in current in high K+
and Rb+ (n = 18 for K+, n = 17 for Rb+) compared to activation measured in ND96 (n = 30). Signiﬁcance of mean differences was evaluated by one-way
ANOVA and posthoc mean comparison Tukey test (ns for p > 0.05, *p < 0.05). d, e Current-voltage relationship for hKv7.1 expressing oocytes in the
absence (black, n = 18 for K+ and Rb+) and presence (gray, n = 17 for K+, n = 18 for Rb+) of 1 µM (R)-L3 in 100 mM K+ (d) and 100 mM Rb+ (e). V1/2
values were determined from normalized peak tail currents at −120 mV for each oocyte and ﬁtted to Boltzmann equation. f, g Slow deactivation
component of hKv7.1 in high K+ (f) and high Rb+ (g) in the absence (black; n = 15 for K+, n = 18 for Rb+) and the presence (gray; n = 9 for K+ and n = 18
for Rb+) of (R)-L3. Time constants τslow deact were determined by two-component exponential ﬁt for each oocyte and voltage step. h Depiction of KCNQ1 in
activated state (AO, derived from Kuenze et al38. Amino acids crucial for (R)-L3 activity (magenta) are located at the lower S5 (green) and S6 (blue) helix.
Most side chains of the crucial amino acids are orientated to the S4S5 Linker (orange) and VSD (yellow) of an adjacent KCNQ1 subunit.
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Fig. 3 (R)-L3 potentiates Kv7.1VCF (C214A/G219C/C331A) currents and left shifts the voltage-dependence of G/Gmax and dF/F. a Whole-cell currents
from an oocyte expressing Kv7.1VCF labeled with Alexa 488 C5 maleimide. Every 15 s, the membrane voltage was pulsed from the −80 mV resting potential
to +60 mV for 4 s, followed by 2 s tails at −40 mV. Currents before (black) and after (red) a bolus of (R)-L3 was added to the bath (ﬁnal concentration
~10 μM). b Steady-state current at +60 mV versus time during application of (R)-L3 (indicated by red bar). Blackline represents the mean value, gray dots
represent raw data from each measurement (n = 4). c Pulse protocol for simultaneous current and ﬂuorescence recordings in (d-g). d Sample current trace
from a single oocyte before (black) and after (red) exposure to ~10 μM (R)-L3. e G/Gmax voltage relationship of Kv7.1VCF expressing oocytes in the absence
(black) and presence (red) of (R)-L3 (n = 4 for both conditions). f Sample ﬂuorescence trace from an oocyte before (black) and after (red) exposure to
~10 μM (R)-L3. g dF/F voltage relationship of Kv7.1VCF expressing oocytes in the absence (black) and presence (red) of (R)-L3 (n = 4 for both conditions).

conducted current. We utilized the Kv7.1-construct Kv7.1VCF in
which two extracellularly accessible cysteines (C214A/C331A)
were removed and a novel cysteine (G219C) was introduced in
the VSD for site-speciﬁc attachment of Alexa 488-C5 maleimide.
Kv7.1VCF allows for monitoring of voltage-dependent VSD
movements30,31. Since mutations can alter the activity of channel
modulators, we ﬁrst examined the effect of a high (R)-L3 concentration (10 µM) on the Kv7.1VCF channel. As illustrated in
Fig. 3a, b, 10 µM (R)-L3 are able to activate the Kv7.1VCF channel
by 58 ± 20% (n = 4, SEM). Although the activity of (R)-L3 is
reduced compared to wildtype channels, the activation is still
sufﬁcient to analyze the effects of (R)-L3 on VSD movement by
simultaneous recordings of current and ﬂuorescence for each
oocyte (Fig. 3c–g). Similar to the observed effects on the wildtype
channel (R)-L3 shifts the V1/2 of Kv7.1VCF for G/Gmax from
−58 ± 2 mV (SE, n = 4) to −79 ± 3 mV (SE, n = 4) indicating a
conserved mechanism of action for the mutated channel (Fig. 3d,
e). To ensure that the shift of V1/2 for G/Gmax is not exclusively
caused by the modulation of the pore domain, the change of
ﬂuorescence, which is caused by VSD movement, was simultaneously recorded. Detected ﬂuorescence change (dF) clearly
shows a similar left-shift of V1/2 in the presence of (R)-L3 from
−53 ± 1 mV (SE, n = 4) to −70 ± 1 mV (SE, n = 4) indicating an
altered movement and therefore a direct effect on the VSD by
(R)-L3 (Fig. 3f, g).
Interactions with the lower S4 identiﬁed by alanine scanning.
Indeed, the large benzodiazepinic region of (R)-L3 was proposed
to bind to the outer S5, which in turn is expected to interact with
4

the VSD of Kv channels in open or inactivated states32. Thus, the
binding site may overlap with the interaction surface between
VSD and PD. Speciﬁcally, the lower S4 helical transmembrane
segment and the benzodiazepinic part may interact with similar
regions of the lower S5. To identify single interacting amino acids,
that are responsible for the modulation of VSD movements by
(R)-L3, we performed alanine-scanning mutagenesis of the lower
S4 transmembrane segment (residues 235–241) and evaluated if
the modulatory effects of (R)-L3 on current amplitude and
channel kinetics were preserved (Fig. 4). Since mutations in the
S4 helix itself can alter channel properties, measurements of the
same mutant or wildtype channel in the absence of (R)-L3 serve
as a control (Fig. 4a–d). We found that (R)-L3 effects on current
amplitude could be unaffected (I235A, M238A, L239A, and
V241A), signiﬁcantly increased (R237A and H240A) or decreased
(L236A) by the respective amino acid exchange (Fig. 4e). These
results indicate, that L236, R237, and H240 are involved in the
modulatory mechanism of (R)-L3.
As the modulator slows activation and deactivation kinetics in
wildtype channels the effect on kinetics of mutant channels was
assessed and compared to the kinetics of the same mutant
channel in the absence of (R)-L3. For all mutant channels except
I235A no signiﬁcant alteration of activation kinetics was observed
indicating a direct or indirect involvement of these residues in the
molecular mechanism of (R)-L3 (Fig. 4f, g). While the (R)-L3
effect of slowed deactivation is still present for L236A, H240A
and V241A, the mutations I235A, R237A, M238A, and L239A
show no impact on deactivation behavior in the presence of (R)L3 (Fig. 4h, i). Interestingly, the previous coupled effects on
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Fig. 4 Sensitivity of S4 residues to (R)-L3 modulation. a–d Representative current traces of wildtype (a) and mutant channels L236A (b), R237A (c) and
H240 (d). e Current amplitude activation of Kv7.1 channel mutants by 1 µM (R)-L3 expressed as percent change in current measured at the end of a 7-s
pulse to +40 mV (n = 30 for WT, n = 13 for I235A, n = 18 for L236A, n = 12 for R237A, n = 18 for M238A, n = 13 for L239A, n = 12 for H240A, n = 16 for
V241A). Signiﬁcance of mean differences was evaluated by one-way ANOVA and posthoc mean comparison Tukey Test (*p < 0.05, **p < 0.01,
***p < 0.001). f–i Effect of (R)-L3 on hKv7.1 channel mutant activation and deactivation rates. Kinetics were evaluated in both absence and presence of 1 µM
(R)-L3 and ﬁtted by two-component exponential function (number of independent oocytes for (f–i) are given in SI Table 3).

channel kinetic and current amplitude by (R)-L3 become more
uncoupled by the examined mutations of the lower S4.
Summarizing the results, only mutations from R237 to L239
were able to eliminate both effects on channel activation and
deactivation kinetics. Out of these residues, the mutation M238A
showed the most prominent reduction of the agonistic effect on
the current amplitude.
M238 plays a crucial role in (R)-L3 mechanism and VSD-PDcoupling. To assess the relevance of key interacting residue M238
for (R)-L3 agonism in normal channel gating we conducted
photo-crosslinking experiments (Fig. 5a–f). Modeling suggests a
possible physical interaction of M238 with outer pore of a
neighboring subunit by the S5 residue I274 in the activated state
(Fig. 5c). This hypothesis is supported by the published cryo-EM
structures of KCNQ1 (PDB ID 6UZZ), which shows the VSD in
an activated state33. The rearrangement of the VSD leads to
distinct rotation as well as upward movement of S4 resulting in
direct interaction with S534. Consequently, the distance between
M238 and I274 is reduced in silico entering a range, where direct
interactions are possible. The putative interaction was evaluated
by incorporating the photo-activatable non-canonical amino acid
p-azido-phenylalanine (AzF) at position Kv7.1 M238 (M238AzF)
using the amber suppression method in HEK cells (Fig. 5a–d)35.
Application of high K+ buffer (137 mM) depolarized cells
favoring voltage sensors in the activated up-state, which led to
M238AzF-mediated inter-subunit photo-crosslinking, as shown
by the formation of Kv7.1 multimers in Western blots (Fig. 5e).
These observations are consistent with the proposed interaction
between M238AzF and a neighboring subunit pore domain (S5S6), which is expected to result in covalent inter-subunit bonds.
As an alternative but much less site-speciﬁc approach, we assessed the global incorporation of photo-methionine (pMet). Similar
to the results for M238AzF, pMet incorporation allowed for
photo-crosslinking and stable formation of Kv7.1 multimers in
Western blots in high K+ solution (Fig. 5e). These two different
crosslink experiments support a M238-inter-subunit interaction.
To verify this again, we chose a second experimental approach

addressing the inter-domain interaction with Co2+ ions, that can
facilitate cysteine bridges, and the Kv7.1 double mutant M238C/
I274C (see materials and methods). Oocytes expressing the
wildtype channel as well as the single mutants Kv7.1 M238C and
Kv7.1 I274C serve as negative controls (Fig. 5f, SI Fig. 2). For
Kv7.1 wt, Kv7.1 M238C and Kv7.1 I274C expressing oocytes no
signiﬁcant changes of activation currents were observed in the
presence of Co2+. However, the double mutant Kv7.1 M238C/
I274C showed signiﬁcantly reduced activation current in the
presence of Co2+ ions indicating locked VSD and PD interaction.
Interestingly, the reduction of activation current was reversible by
the addition of (R)-L3. Together with the results from western
blotting these data clearly show the importance of M238 and I274
interaction for channel opening. The data extend and support the
previous ﬁndings of the coupling mechanism and characterize
M238 as a key residue for VSD coupling with the pore36,37.
In silico analyses of the (R)-L3 binding process to the Kv7.1
channel. To connect the experimental data with structural analyses of the ligand/receptor complex and the protein movement,
we used previously described models of different ion channel
states for docking of (R)-L3 and subsequent molecular dynamics
(MD) simulations38. The used ion channel models are homotetrameric structures composed of four α-subunits (Mol A–Mol
D) and display the receptor with an activated VSD and an open
pore (AO), an activated VSD and a closed pore (AC) and a
resting VSD with closed pore (RC). Using the results from
mutational analysis we built complexes of (R)-L3 and the three
different receptor states (AO, AC, RC) by manually docking the
ligand into the pocket between S4 and the S4S5 linker of Mol B
with the indol-3-yl moiety orientated between the α-helices S5
and S6 from Mol A (Fig. 6a–c). The generated ligand/receptor
complexes were energy minimized and embedded into lipid
membranes surrounded by water molecules (Fig. 6d). After second annealing and energy-minimization step, MD simulations
with a duration of 30 ns were performed 3 (RC, AC) or 5 (AO)
times for the generated ligand/receptor complexes.
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Fig. 5 Photo-crosslinking of the photo-activatable non-canonical amino acid AzF leads to formation of multimers. a, b Using the amber suppression
methodology for incorporation of non-canonical amino acids (ncAAs), we introduced the photo-activatable non-canonical amino acid AzF (b) at M238
position into mutant Kv7.1-EGFP-M238AMBER-Stop. HEK cells were co-transfected with cDNA encoding Kv7.1-EGFP-M238amber-Stop, suppressor tRNA
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For analysis of MD simulations, we used parameters like the
root mean square deviation (RMSD), root mean square ﬂuctuation (RMSF) and the movement correlation of residues expressed
by dynamic cross-correlation matrices (DCCMs). The RMSD can
be calculated for multiple or single amino acids or even atoms
and displays the total movement from the beginning of the
simulation to the end, while RMSF displays the ﬂuctuation
around a mean position. After 30 ns of simulation, the total
RMSD of the ligand/receptor complexes was constantly ﬂuctuating around a steady-state value indicating a stable formation.
Although the total RMSDs decrease from the AO-complexes to
the RC-complexes, the means were not signiﬁcantly different
(Fig. 6e). In contrast, the RMSD for (R)-L3, which displays the
movement of the ligand away from the energy minimized starting
position, was signiﬁcantly reduced for the AO-complex (Fig. 6f).
Since the RMSF of the ligand did not signiﬁcantly differ, the
different RMSDs must be caused by a movement of the complete
ligand instead of a reorientation of ligand site chains (Fig. 6g). All
simulated complexes show a constantly ﬂuctuating ligand RMSD
after an equilibration time of 10 ns. Therefore, the binding energy
for every ligand/receptor complex was calculated from 10 ns to
30 ns every 0.25 ns. The highest binding energies were observed
in the AO-complexes indicating a better binding of (R)-L3 to this
ion channel state (Fig. 6h). Together with the reduced ligand
RMSD in the AO state, these results lead to the conclusion of a
favored binding to the fully activated AO receptor state.
Aromatic interactions between (R)-L3 and W248 are crucial for
the activity. Hence, we focused on the AO-ligand/receptor
complex and analyzed interactions between (R)-L3 and the
6

mutated amino acids of the lower S4 segment. Only hydrophobic
interactions with L236, M238, L239, and V241 were detected.
Additionally, a strong aromatic interaction between W248 from
the S4S5 linker (Mol B) and the 2-chlorophenyl moiety was
observed. Figure 6i shows the relative interaction duration over
the complete simulation time, which indicates a strong inﬂuence
of W248 on the binding. Consequently, we included W248 into
further analyses. While distinct interactions with the receptor are
needed for compound binding, the mechanism of activation is
conducted by altered movements of the protein in the presence of
the ligand. To detect these movements, we performed three
additional 30 ns MD simulations of the AO state model without
the ligand for comparison. Surprisingly, the examined amino
acids in S4 (Mol B) did not show signiﬁcantly different RMSD or
RMSF values indicating a similar behavior for the presence and
absence of (R)-L3 (Fig. 6j, k). In contrast, the RMSD of W248
from the S4S5 linker (Mol B) was signiﬁcantly reduced without a
signiﬁcant change in the RMSF suggesting an inhibited movement of the amino acid in the presence of (R)-L3.
Due to the frequently detected aromatic interactions with the
ligand in silico and the altered behavior of W248 in the presence
of (R)-L3 additional mutants W248F, W248A, and W248R were
generated. TEVC measurements revealed a signiﬁcant loss of (R)L3 activity for all mutants compared to wildtype emphasizing the
involvement of W248 in the molecular mechanism of action
(Fig. 6l). Comparing the activity of 1 µM (R)-L3 on aromatic
mutant W248F (34 ± 6%, SEM, n = 5) with activity on W248A
(20 ± 6%, SEM, n = 5) and W248R (10 ± 3%, SEM, n = 4) lead to
the conclusion that not only the size but also the aromaticity of
the amino acid at this position seems important for the agonistic
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Fig. 6 Binding site localization and in silico simulation results. a Depiction of tetrameric KCNQ1 AO model with subunits colored in magenta (Mol A),
yellow (Mol B), green (Mol C) and blue (Mol D). Proposed binding site of (R)-L3 is marked by red square. b Close-up depiction of (R)-L3 (CPK-color coded
with cyan for carbon) binding site with S4 (yellow) and S4S5 linker (orange) from subunit Mol B and S5 and S6 helix (magenta) from subunit Mol A.
Previous analyzed amino acids from S5 and S6 with impact on (R)-L3 activity are colored in purple, while newly analyzed residues from S4 and S4S5 linker
are colored in green or violet. c Schematic illustration of (R)-L3 binding site between S4 (yellow) and S4S5 linker (orange) from subunit Mol B and S5 and
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Root mean square ﬂuctuation (RMSF) for 30 ns MD simulation with KCNQ1 state models AO (n = 5), AC (n = 3) and RC (n = 3). Mean differences are not
signiﬁcant (ns; p > 0.05). h Binding Energy [kJ/mol] of (R)-L3 calculated for all simulation snapshots from 10 to 30 ns of MD simulations for KCNQ1
models AO (n = 405 snapshots), AC (n = 243) and RC (n = 243). i Percentage duration of hydrophobic interaction between (R)-L3 and mutated amino
acids from S4 and S4S5 linker over total MD simulation time of 30 ns for AO simulations (n = 5). j, k Backbone RMSD and RMSF of mutated residues in
the absence (n = 3 simulations)/presence (n = 5 simulations) of (R)-L3. l activity of 1 µM (R)-L3 at wildtype KCNQ1 expressing oocytes compared to
mutations W248F, W248A, and W248R (n = 4 for WT, n = 5 for W248F, W248A, and W248R).
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mechanism. Since aromatic interactions are also possible with
phenylalanine the mutant W248F represents only a partial
disruption of compound/channel interaction at this position.
This hypothesis is also consistent with the activation and
deactivation parameters of the W248 mutants in the presence
and absence of (R)-L3 (SI Fig. 3). Whereas no signiﬁcant
alteration of activation or deactivation time constants upon (R)L3 application is observed at W248A and W248R expressing
oocytes representing a disruption of kinetic modulating effects by
(R)-L3, W248F expressing oocytes show signiﬁcant alteration in
deactivation kinetics in the presence of (R)-L3, which is also
found in wildtype channels.
VCF measurements for putative interacting amino acids. To
characterize the inﬂuence of the most important interacting
amino acids M238, V241, and W248 in more detail we tried to
record further VCF experiments using the alanine mutants of
these residues. However, sufﬁcient ﬂuorescence signals were only
detected for the mutation V241A (SI Fig. 4). The fact that low
currents in TEVC mirrors insufﬁcient labeling site-speciﬁc
attachment of Alexa 488-C5 maleimide allowing for VSD suggests weak plasma membrane expression of these mutants as
described for S4 mutated KCNQ1 channels before39–41. As VCF
is a method with low signal-to-noise ratio, several mutated weakly
expressing Kv7.1 channels could not be analyzed. Compared to
the wildtype channel, Kv7.1VCF V241A showed right-shifted V1/2
values of −29 ± 1 mV (G/Gmax) and −25 ± 1 mV (dF/F). In the
presence of (R)-L3 the typical left-shift to more negative values is
observable with V1/2 values of −35 ± 1 mV (G/Gmax) and
−29 ± 2 mV (dF/F). However, compared to the wildtype these
shifts are much less pronounced consistent with a direct involvement of compound/residue interaction in the agonistic
mechanism.
Inﬂuence of (R)-L3 binding on VSD-PD-coupling in silico.
While only minor differences are found on the scale of single
interacting amino acids, major differences were observed in the
communicational behavior of the binding site forming segments
S4 (Mol B), S4-S5 linker (Mol B), S5 (Mol A), and S6 (Mol A)
(Fig. 7a). To visualize the altered communication between the
segments, DCCMs were calculated for all simulations and averaged depending on the presence or absence of (R)-L3 (Fig. 7b–j).
DCCM was calculated for a pair of Cα atoms over the complete
MD simulation time and displayed movement behavior of the
selected atoms in a range from −1 (fully anticorrelated movements) over 0 (no movement correlation) up to 1 (fully correlated
movements). Although the S4 helix (Mol B) and the S4S5 linker
(Mol B) are in close distance and on the same subunit their
movements were not coordinated in the simulations without (R)L3 (Fig. 7b). In the presence of the ligand a clear increase of
coordinated movements could be observed between the lower
S4 segment with the adjacent residues from the S4S5 linker
(Fig. 7c, d). In contrast, the natural communication and the
movement correlation between S4 (Mol B) and the corresponding
S5 helix (Mol A) was nearly abolished (Fig. 7e–g). In accordance
with the reduced correlation between S4 and S5 also the simultaneous movements of S5 and the S4S5 linker were reduced (SI
Fig. 5a–c). The presence of (R)-L3 generated also weak coupling
between S4 (Mol B) and S6 (Mol A), while under normal condition no long-range coupling could be detected between these
segments (Fig. 7h–j). In particular, the movement correlation
between M238 and surrounding residues from S4 with the residues A336 – F340, which are directly interacting with (R)-L3, was
increased. However, these differences were less pronounced than
the coupling changes between S4, S4S5 linker and S5. A more
8

pronounced elevation of coupling was achieved by (R)-L3 for the
lower S6 helix with the whole S5 helix (SI Fig. 5d–f), while at the
same time S6 was uncoupled from the movements of the S4S5
linker (SI Fig. 5g–i). Summarizing the movement coupling, the
presence of (R)-L3 separated the movements of the VSD from the
PD by decreasing the correlation between S4 and S5 and simultaneously increasing the correlation between S4 and S4S5 linker
and between the inner pore domain forming helices S5 and S6.
Since (R)-L3 increases Kv7.1 current amplitude, an allosteric
coupling between the binding site forming structures and the
adjacent selectivity ﬁlter residues can be assumed (Fig. 8a).
Hence, RMSDs of amino acids V310–P320 (Mol A) and the
coupling of these with S4, S4S5 linker, S5 and S6 were analyzed
(Fig. 8b–o). Comparing the residue backbone RMSD in the
absence and presence of (R)-L3, the amino acids V310–T312 and
K318–P320 showed a moderate, but not signiﬁcant increased
movement when the ligand is bound (Fig. 8b). However, the
averaged backbone RMSD for V310–P320 was signiﬁcantly
increased suggesting an elevated movement of the whole
selectivity ﬁlter segment (Fig. 8c). Similar to previous results for
S4, the movement correlation of S4 with the selectivity ﬁlter
decreased. In particular, the correlation between M238 and the
lower residues was extinguished by the ligand (Fig. 8d–f). In
contrast, a slightly increased movement correlation occurred
between the S4S5 linker and the lower amino acids of the
selectivity ﬁlter (Fig. 8g–i). While the outer structures showed
only minor correlation differences with V310–P320, the two
inner helices S5 and S6 nearly swap their behavior towards the
selectivity ﬁlter (Fig. 8j–o). S5 loosed correlation especially to the
amino acids T312–K318, while S6 achieves a higher grade of
correlation with the lower selectivity ﬁlter. Especially F339, which
is directly connected to the indol-3-yl moiety of (R)-L3 via
aromatic interactions, ampliﬁed its movement coupling with
V310–I313. In summary, (R)-L3 raised the mobility of
V310–P320 and altered the coupling of these residues by
enhancing the movement correlation with S6 and simultaneously
decreasing it with S4 and S5.
Discussion
In the present study, we analyzed the binding site and mechanism
of action of the known Kv7.1 modulator (R)-L3, which slows
down channel activation and deactivation and increases current
amplitude (Fig. 1)23. Current amplitude, inactivation, activation
and deactivation kinetics are dependent on the external ion
species, via allosteric effects within the pore domain19,26. Based
on this phenomenon, we used different external ion solutions to
evaluate if the effects of (R)-L3 are resulting from direct modulation of the PD. Indeed, the increment of corrected tail current
amplitude by (R)-L3 is reduced in 100 mM K+ as well as in
100 mM Rb+ and therefore dependent on the external ion species
and concentration (Fig. 2c). On the other hand, residues in the
S5-S6 pore domain have been identiﬁed to be involved in both,
the formation of the (R)-L3 binding site23 as well as the formation
of an allosterically linked cluster among lower selectivity ﬁlter. In
particular, Y267, I268, and L271 are crucial for the activity of (R)L3. These residues were also directly involved in the in silico
binding of (R)-L3 forming aromatic and hydrophobic interactions with the compound (Fig. 6b). Thus, S5 and S6 determine
current amplitudes and inactivation19,26,42. The modulator may
allosterically inﬂuence the conduction pathway to allow for
increased conduction rates. This is also indicated by the increased
RMSD of the residues forming the selectivity ﬁlter (Fig. 8c). In
contrast, (R)-L3 effects on current deactivation kinetics are
similar in high Na+, K+ and Rb+ (Fig. 2F, G, SI Fig. 1) which
indicates that the activity of the modulator can be functionally
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b, c Dynamic cross-correlation matrix (DCCM) for S4 (Mol B, yellow) and S4S5 linker (Mol B, orange) in the absence (b) and presence (c) of (R)-L3 from
−1 (fully anticorrelated) over 0 (not correlated) to 1 (fully correlated). d Increase (positive values, red) and decrease (negative values, blue) of correlation
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COMMUNICATIONS BIOLOGY | (2022)5:301 | https://doi.org/10.1038/s42003-022-03229-8 | www.nature.com/commsbio

9

ARTICLE

COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-022-03229-8

b

V310

RMSD [Å]

P320

c
6

6

5

5
RMSD [Å]

a

4
3
2

4
3
2

1

1

0

0

e

d

D242

D242

M238

M238

M238

Q234

Q234

1

0.5 Q234

I230

I230

0

A226

A226

-0.5 A226

I230

-1

R259

R259

V255

V255

V255

L251

L251

L251

T247

T247

T247

k

0.6
0.4
0.2
0
-0.2
-0.4
-0.6

l

A283

A283

A283

F279

F279

F279

F275

F275

F275

L271

L271

L271

Y267

Y267

Y267

I263

I263

I263

n

m

- (R)-L3

i

h
R259

j

+ (R)-L3

f

D242

g

***

o

A344

A344

F340

F340

F340

A336

A336

A336

F332

F332

F332

I328

I328

I328

V324

V324

V324

A344

Fig. 8 Dynamic cross-correlation matrices (DCCMs) for interactions between Pore helix and S4-S6. a Close-up depiction of (R)-L3 binding site with S4
(yellow), S4S5 linker (orange), S5 (green), S6 (blue) and selectivity ﬁlter (purple) with all amino acids from V310 to P320. b, c RMSD of selectivity Filter
residues V310 – P320 individually (b) and in total (c) in the absence (black) and presence (red) of (R)-L3. Means are given as squares (b) or bars (c).
(d, e) Dynamic cross-correlation matrix (DCCM) for S4 (Mol B, yellow) and selectivity ﬁlter (Mol A, purple) in the absence (d) and presence (e) of (R)-L3
from −1 (fully anticorrelated) over 0 (not correlated) to 1 (fully correlated). f Increase (positive values, red) and decrease (negative values, blue) of
correlation between S4 and selectivity ﬁlter residues depending on the presence of (R)-L3. g, h DCCM for S4S5 linker (Mol B, orange) and selectivity ﬁlter
(Mol A, purple) in the absence (g)/presence (h) of (R)-L3. (i) Increase (positive values, red) and decrease (negative values, blue) of correlation between
S4S5 linker and selectivity ﬁlter residues depending on the presence of (R)-L3. j, k DCCM for S5 (Mol A, green) and selectivity ﬁlter (Mol A, purple) in the
absence (j)/presence (k) of (R)-L3. l Increase (positive values, red) and decrease (negative values, blue) of correlation between S5 and selectivity ﬁlter
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separated in a stimulation effect of current amplitude via modulation of the conduction pathway and a second (R)-L3 effect on
current kinetics by a different mechanism.
The (R)-L3 impact on current kinetics could result from altered
voltage-sensor movement. To conﬁrm this hypothesis, voltageclamp ﬂuorometry (VCF) was performed and showed that the
(R)-L3 effects are followed by parallel left shifted GV and FV
curves (Fig. 3). This ﬁnding is consistent with mathematical
modeling suggesting that the modulator favors opened over
closed states23. Thus, beside direct effects on the pore domain
separate effects on the VSD are observable.
By inspection of the Kv7.1 homology model the identiﬁed S5S6 residues suggest a binding site from the interface of S5 and S6
(indol-3-yl sidechain) to the outer S5 (benzodiazepinic part).
Especially in activated VSD state, the outer S5 of Kv channel
subunit is expected to be located in close proximity of the primary
voltage sensing helix S4 of the adjacent subunit, suggesting that
(R)-L3 may interact with S4 as well. Usage of classical mutagenesis scanning of the lower S4 identiﬁes several residues
modulating the activation of Kv7.1 channels. The most dramatic
impacts on (R)-L3 effects were seen with mutation at R237 and
M238 whose signiﬁcantly blunted current potentiation and
kinetic modulation (Fig. 4, SI Fig. 3a). Other mutants impaired
compound effects on either activation or on deactivation or on
current amplitudes but not on all parameters. However, due to
sidechain orientation direct interactions between residue and
compound are only possible for M238 in silico inspecting both
available cryo-EM structures33,43. Therefore, M238 may be considered a key residue for (R)-L3 activity.
Recently, a two-stage hand-and-elbow gating mechanism for
Kv7.1 was proposed. S4 movement towards a fully activated
conductive state depends on an elbow-like hinge between S4 and
S4S5 linker that engages with the pore of the neighboring subunit
to activate conductance37. Based on this open state model interaction of M238 with the neighboring S5-S6-domain can be predicted in silico. In order to test this hypothesis in vitro we adapted
a photo-crosslinking approach and show crosslinking of
M238AzF with the neighboring subunit in the open state (Fig. 5).
Further, the functional inﬂuence of the inter-domain interaction
of M238 was assessed by CoCl2 conﬁrming our hypothesis. Since
the distance between M238 and I274 is depending on VSD
conformation, the interaction between these residues is favored in
the activated VSD state. Thus, M238 was identiﬁed as a key
residue for (R)-L3 activity as well as a potential key player for the
VSD-PD-coupling.
In order to evaluate the binding site further we used different
Kv7.1 channel models (AO, AC, and RC state) and manually
docked the (R)-L3 molecule assuming close proximity of key
residues. Thus, guided by the experimentally identiﬁed key residues in S5/S623 and S4 (M238) we developed an in silico model
(Fig. 6). In MD simulations (R)-L3 was stably coordinated over
24 ± 5.45 ns (n = 5) only to the AO model to the postulated
binding pocket in close proximity of the key residues suggesting
favorable binding only in the fully activated state. By inspection of
the model complex, residue W248 in the S4S5 linker was identiﬁed as a likely interaction partner. To verify our model and the
inﬂuence of W248 in vitro, we mutated the natural tryptophan
and found that it is highly important for the activity of the
modulator on the Kv7.1 channel (Fig. 6d). Therefore, extensive
evidence suggests that (R)-L3 binds in a binding pocket formed
by S4, S4-S5 linker and the pore domain S5/S6 of the neighboring
Kv7.1 channel subunit, which is exactly the key region of electromechanical coupling in Kv7.1-voltage-dependent activation37.
(R)-L3-induced uncoupling of key residue M238 from the
neighboring S5-S6-domain and the lower K+-coordinating residue T331 in the lower selectivity ﬁlter in the open state may allow
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for higher conduction. Stabilization of interactions between the
hand-like C-terminus of the VSD-pore linker (S4-S5L) with the
pore (S5-S6) stabilizes the fully activated state conformation as
suggested by kinetic Markov modeling. Further, a straightened S6
helix allows for KCNQ1-typical structure-function coupling with
impact on deactivation and selectivity ﬁlter function42,44. In
addition, this hypothesis is in good accordance with the correlated movement of M238 and the segments S4S5 linker and
selectivity ﬁlter. Without (R)-L3 the movement of M238 correlates with residues from the selectivity ﬁlter (Fig. 8d; residues
V310-Y315), especially with T312, while no coordinated movement can be seen with the S4-S5 linker (Fig. 7c). In the presence
of (R)-L3 this behavior towards the linker and the selectivity ﬁlter
is reversed underlining the separation of VSD and pore domain
by the compound.
Recently, quercetin was identiﬁed as activator of homomeric
KCNQ1 channels45. The mechanism of KCNQ1 current potentiation results from an accelerated activation as well as decelerated deactivation. Similar to (R)-L3, a possible binding site for the
compound was detected in close proximity to F340, which is
located on the lower S6 helix. Functional analysis of F340V show,
that this residue is directly or allosterically involved in the activation mechanism provided by quercetin. On the other hand,
docking studies as well as further functional analyses indicate
quercetin binding to at least one additional and independent
binding site, which is also functionally important for the
mechanism of action. Thus, quercetin seems less speciﬁc and less
potent compared to (R)-L3.
Summarizing, this study provides evidence for two individual
molecular mechanisms allowing Kv7.1 channel activation by (R)L3: Firstly, current amplitudes are increased due to compound
binding to the pore domain allosterically modulating the ion
pathway. Secondly, Kv7.1 channels may be trapped in open states
by the stabilization of the voltage sensors in the activated state
(up-state).
Materials and methods
Mutagenesis and heterologous expression of potassium channels. Sitedirected mutagenesis of Kv7.1 cDNA (GenBank Acc. No. NM_000218) subcloned
into the pXOOM vector was performed using standard mutated oligo extension
PCR. Mutations were veriﬁed by automated DNA sequencing. The constructs were
linearized with NheI, and in vitro transcriptions were performed using the
mMessage mMachine kit (Ambion) with T7 polymerase according to the manufacturer’s instructions. The quality of synthesized RNA was checked by gel electrophoresis and quantiﬁed by spectrophotometry.
Oocytes were isolated from ovarian lobes of Xenopus laevis and enzymatically
digested with collagenase (Type II, Worthington, 1 mg/ml in calcium-free Barth’s
solution) for about 1.5–2 h, as previously described. Stage IV or V oocytes were
injected with 5 ng cRNA encoding either wildtype or mutant Kv7.1 subunits and
stored for 3–4 days at 18 °C in Barth’s solution containing (in mmol L−1): 88 NaCl,
1.1 KCl, 2.4 NaHCO3, 0.3 Ca(NO3)2, 0.3 CaCl2, 0.8 MgSO4, 15 HEPES-NaOH,
penicillin-G (31 mg L−1), gentamycin (50 mg L−1), streptomycin sulfate (20 mg L−1),
pH 7.6 before electrophysiological recording.
Electrophysiology and Co2+ crosslinking. Whole-cell currents in oocytes were
recorded at room temperature by two-electrode voltage-clamp (TEVC) using a
Turbo Tec 10CD ampliﬁer (NPI Electronic GmbH, Tamm, Germany) and an ITC16 interface combined with GePulse software (Michael Pusch, Genova, Italy).
Recording pipettes pulled from borosilicate glass were ﬁlled with 3 M KCl and had
resistances of 0.4-1 MΩ. Recordings were performed in ND96 solution containing
(in mmol L−1) 96 NaCl, 4 KCl, 1 CaCl2, 1.8 MgCl2, 5 HEPES, pH 7.2–7.4 with
0.1% dimethylsulfoxide. For experiments with high extracellular potassium or
rubidium concentrations, standard ND96 solution was replaced by 100 mM KCl
and 100 mM RbCl solution, respectively. (R)-L3 was added to each bath solution to
give a ﬁnal concentration of 1 μM, from a 10 mM stock solution in DMSO. To
determine the effects of (R)-L3 on wildtype and mutant Kv7.1 channels, currents
were recorded by repetitive 7-second pulses to potentials of −100 mV to +60 mV,
applied in 20 mV increments and then held for a 3-second tail pulse at −120 mV
before returning to the holding potential of −80 mV. Mutations can have an
inﬂuence on channel gating kinetics, plasma membrane expression and subsequently on the current amplitude. Wildtype and mutant channels expressed in
Xenopus laevis were only used if the current at +40 mV was ≥0.5 µA, which is
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robust enough for analyses. Throughout the manuscript, (R)-L3 effects on different
KCNQ1 mutants are always discussed in comparison to the control recording at
the same mutant in the absence of (R)-L3. Therefore, a correlation of plasma
membrane expression and ionic current was not necessary.
Co2+-assisted crosslinking based on the well-characterized afﬁnity of transition
metals to sulfhydryl groups of cysteines46. Formation of those metal-assisted
bridges is only possible, if Co2+ ion as well as sulfhydryl groups of two cysteines are
in the right distance and angle to each other47,48. As a result of formation
conformational changes can be restricted and subsequently protein function can be
disturbed. For the Co2+-assisted cysteine crosslinking oocytes were injected right
before measurements with 2 mmol L−1 CoCl2 and expressed channels were
activated by +40 mV voltage pulse in the presence and absence of (R)-L3. The
resulting current was normalized to oocytes expressing the same Kv7.1 variant
without CoCl2 injection and without (R)-L3 application.
Data Analysis. Data were analyzed with the custom program Ana and GraphPad
Prism 5.01 software (GraphPad Software, San Diego, California). All experimental
results are presented as mean ± SEM with n specifying the number of independent
experiments. Statistical analysis was performed with Student’s t test (unpaired) or
ANOVA. The activation curves for wildtype and mutant Kv7.1 channels were
determined from tail currents at hyperpolarized potentials by plotting the normalized peak tail current amplitudes versus the respective test potential. The
resulting curves were ﬁtted to a Boltzmann equation that gave an adequate ﬁt with
the two parameters V1/2 (voltage of half-maximal activation) and the slope factor k.
Activation kinetics was obtained by double-exponential ﬁts to the currents yielding
fast and slow time constants of activation. Deactivation rate constants were also
obtained by double-exponential ﬁts to the tail currents in the absence and presence
of (R)-L3 and plotted against the applied membrane potential.
Methods of voltage-clamp ﬂuorometry (VCF). Oocytes were injected with 9.2 ng
of cRNA encoding of psWT Kv7.1 (C214A/G219C/C331A) alone or simultaneously
with 2.3 ng of cRNA encoding wt CiVSP. After incubation for 3–7 days at 18 C, the
cells were labeled in high K+ labeling solution (98 mmol L−1 KCl, 1.8 mmol L−1
CaCl2, 5 mmol L−1 HEPES, pH 7.6) with 10 μM Alexa 488 C5-maleimide (Molecular Probes) for 45 min on ice, washed with ND96 solution (96 mmol L−1 NaCl,
4 mmol L−1 KCl, 1.8 mmol L−1 CaCl2, 1 mmol L−1 MgCl2, 5 mmol L−1 HEPES),
and kept on ice until recording to minimize recycling of labeled channels. VCF
recordings were carried out in ND96 solutions + /- (R)-L3. Fluorescence recordings were performed using a Leica DMLFS upright ﬂuorescence microscope with a
FITC ﬁlter cube. Emission from the animal pole was focused onto a pin 20 A
photodiode (OSI Optoelectronics) and ampliﬁed using an EPC10 (HEKA) patch
ampliﬁer and analog ﬁltered at 200 Hz. Simultaneous two-electrode voltage-clamp
recordings were measured using a Dagan CA1-B ampliﬁer in TEVC mode. Current
and ﬂuorescence signals were digitized at 1 kHz.

S6 (Mol A) followed by a second energy minimization using AMBER1423. For MD
simulation in a lipid membrane, the provided YASARA 19 macro md_runmembrane.mcr was used and the following parameters were adapted: Membrane
composition was set to 1/3 phosphatidyl-ethanolamine (PEA), 1/3 phosphatidylcholine (PCH) and 1/3 phosphatidyl-serine (PSE). All polar head groups are 1palmitoyl- and 2-oleoyl substituted. Simulation speed was set to fast (simulation
time steps of 2*2.5 fs) and simulation time was set to 30 ns. Process of simulation
was documented by screenshots every 0.25 ns leading to 120 screenshots in total for
every simulation. RMSD, RMSF, and DCCM were calculated with provided
YASARA macros md_analyze.mcr and md_analyzeres.mcr. Full simulation and
analysis were conducted using AMBER14 force ﬁeld.
Statistics and reproducibility. Where relevant, signiﬁcance of mean differences
for all data was analyzed using OriginPro 2021 by one-way-ANOVA and posthoc
mean comparison Tukey test indicated by *p values < 0.05, **p values < 0.01, ***p
values < 0.001 and ns (not signiﬁcant) for p values > 0.05. Number of individual
oocytes or simulations is given for every experiment in the main article, the ﬁgure
legends, or the Supplementary information. Further, n values can be reconstructed
from Supplementary data for each ﬁgure panel.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
Uncropped and unedited blot image for Fig. 5e is given as SI in the Supplementary
Information. Source data for graphs and charts are given as supplementary data for each
ﬁgure panel as excel sheets. Number of independent oocytes for kinetic parameters in
Fig. 4 and Co2+ measurements are given in SI Table 1 and SI Table 2. Further datasets
generated during and/or analyzed during the current study are available from the
corresponding author on reasonable request.
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